Literature DB >> 10566354

Trial of labor versus elective repeat cesarean section for the women with a previous cesarean section: a decision analysis.

J H Chuang1, R A Jenders.   

Abstract

In order to reduce the cesarean-delivery rate, more and more pregnant women are offered trials of labor (TOL) after their previous cesarean sections. TOL and elective repeat cesarean section (ERCS) have different risks and benefits. We constructed a decision analysis to explore this issue. Probabilities were derived from literature reviews. Health state utilities were derived from the authors' clinical judgement. The analysis considered the disutility of the procedures and the disutilities of the morbidity. Using the baseline assumption, ERCS was superior to TOL. One-way sensitivity analyses showed that the result was insensitive to all of the probability estimates and the disutilities of the morbidity. However, the result was sensitive to the patient's preference for ERCS, successful TOL, or failed TOL. The analysis indicates that the best delivery method for a woman who has had a previous cesarean section depends on patient's preference. More patients' preference studies are needed.

Entities:  

Mesh:

Year:  1999        PMID: 10566354      PMCID: PMC2232472     

Source DB:  PubMed          Journal:  Proc AMIA Symp        ISSN: 1531-605X


  15 in total

Review 1.  Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results.

Authors:  M D Krahn; G Naglie; D Naimark; D A Redelmeier; A S Detsky
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

2.  Vaginal birth after cesarean section: the impact of patient resistance to a trial of labor.

Authors:  G F Joseph; C M Stedman; A G Robichaux
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

3.  Comparison of a trial of labor with an elective second cesarean section.

Authors:  M J McMahon; E R Luther; W A Bowes; A F Olshan
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

4.  Evaluation of elective repeat cesarean section as a standard of care: an application of decision analysis.

Authors:  K K Shy; J P LoGerfo; L E Karp
Journal:  Am J Obstet Gynecol       Date:  1981-01-15       Impact factor: 8.661

5.  Trial of labor following cesarean delivery.

Authors:  R K Cowan; R A Kinch; B Ellis; R Anderson
Journal:  Obstet Gynecol       Date:  1994-06       Impact factor: 7.661

6.  Elective repeat cesarean delivery versus trial of labor: a prospective multicenter study.

Authors:  B L Flamm; J R Goings; Y Liu; G Wolde-Tsadik
Journal:  Obstet Gynecol       Date:  1994-06       Impact factor: 7.661

7.  Vaginal birth after cesarean: a 10-year experience.

Authors:  D A Miller; F G Diaz; R H Paul
Journal:  Obstet Gynecol       Date:  1994-08       Impact factor: 7.661

8.  Vaginal birth after cesarean.

Authors:  J P Phelan; S L Clark; F Diaz; R H Paul
Journal:  Am J Obstet Gynecol       Date:  1987-12       Impact factor: 8.661

9.  Vaginal birth after cesarean: a meta-analysis of morbidity and mortality.

Authors:  M G Rosen; J C Dickinson; C L Westhoff
Journal:  Obstet Gynecol       Date:  1991-03       Impact factor: 7.661

10.  Analysis of factors determining the selection of repeated cesarean section or trial of labor in patients with histories of prior cesarean delivery.

Authors:  J Kline; F Arias
Journal:  J Reprod Med       Date:  1993-04       Impact factor: 0.142

View more
  2 in total

Review 1.  Economic Evaluations Comparing a Trial of Labor with an Elective Repeat Cesarean Delivery: A Systematic Review.

Authors:  Anna Joy Rogers; Nathaniel G Rogers; Meredith L Kilgore; Akila Subramaniam; Lorie M Harper
Journal:  Value Health       Date:  2016-11-11       Impact factor: 5.725

2.  Preferences for mode of delivery after previous caesarean section: what do women want, what do they get and how do they value outcomes?

Authors:  Clare L Emmett; Alan A Montgomery; Deirdre J Murphy
Journal:  Health Expect       Date:  2010-09-23       Impact factor: 3.377

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.